APPLICATION
ANDA202143
TYPE
ANDA
ORIGINAL APPROVAL
2012-01-31
LATEST ACTION
2015-12-28
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
LEVETIRACETAMDiscontinued
LEVETIRACETAM 500MG/5ML (100MG/ML) · INJECTABLE · INTRAVENOUS
Approval history
2015-12-28Labeling · Supplement 3 · standardAP
2015-12-28Labeling · Supplement 4 · standardAP
2015-12-28Labeling · Supplement 2 · standardAP
2012-01-31Not Applicable · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.